Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Azithromycin, pharmacodynamic evaluation in animal models]

P H Lagrange1

  • 1Service de Microbiologie, Hôpital Saint-Louis, Université Paris VII, France.

Pathologie-Biologie
|June 1, 1995
PubMed
Summary

Azithromycin demonstrates comparable efficacy to other antibiotics in acute infections but shows significant advantages in treating local infections and those caused by Gram-negative bacteria. Its unique tissue accumulation enhances efficacy against intracellular pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter evaluation of a transcription-reverse transcription concerted assay for rapid detection of mycobacterium tuberculosis complex in clinical specimens.

Journal of clinical microbiology·2009
Same author

Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.

Tuberculosis (Edinburgh, Scotland)·2008
Same author

Evaluation of the inoculation procedure using a 0.25 McFarland standard for the BD Phoenix automated microbiology system.

Journal of clinical microbiology·2007
Same author

[New immunological tests in the diagnosis of tuberculosis].

Revue des maladies respiratoires·2007
Same author

Molecular diagnosis of pulmonary tuberculosis by automated extraction and real-time PCR on non-decontaminated pulmonary specimens.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007
Same author

[The role of human dendritic cells in tuberculosis: protector or non-protector?].

Revue des maladies respiratoires·2006

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Azithromycin is a macrolide antibiotic with broad-spectrum activity.
  • Evaluating in vivo efficacy against human pathogens is crucial for therapeutic applications.
  • Comparative studies with other antibiotics inform clinical use.

Purpose of the Study:

  • Compare the dose 50 (ED50) of azithromycin with other oral antibiotics.
  • Assess azithromycin's efficacy against intracellular multiplying microorganisms.
  • Demonstrate azithromycin's tissue accumulation and phagocytic cell recruitment at infection sites.

Main Methods:

  • Utilized experimental animal models to evaluate in vivo efficacy.
  • Conducted comparative studies of ED50 for azithromycin, erythromycin, and cefaclor in murine infections.

Related Experiment Videos

  • Employed models with intracellular pathogens like Listeria monocytogenes and Chlamydia trachomatis.

    • Main Results:

    • Azithromycin showed similar efficacy to erythromycin and cefaclor in acute murine infections.
    • Azithromycin exhibited a marked advantage in experimental local infections.
    • Demonstrated superior efficacy against Gram-negative bacteria (Haemophilus influenzae, Branhamella catarrhalis).
    • Confirmed preferential efficacy against intracellular multiplying microorganisms due to phagocyte accumulation.

    Conclusions:

    • Azithromycin offers significant therapeutic advantages over other antibiotics in specific infection types.
    • Its ability to accumulate in tissues and phagocytes underlies its efficacy against intracellular pathogens.
    • Experimental models effectively demonstrate azithromycin's in vivo performance and pharmacokinetic properties.